1. Home
  2. Labeler Index
  3. Sanofi Pasteur Inc.
  4. NDC Product Code: 49281-915 Yf-vax

NDC 49281-915 Yf-vax

Yellow Fever Virus Strain 17d-204 Live Antigen Injection, Powder, Lyophilized, For - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 49281-915?
  4. Yf-vax Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Pharmacologic Classes
  10. Patient Education

Product Information

NDC Product Code:
49281-915
Proprietary Name:
Yf-vax
Non-Proprietary Name: [1]
Yellow Fever Virus Strain 17d-204 Live Antigen
Substance Name: [2]
Yellow Fever Virus Strain 17d-204 Live Antigen
NDC Directory Status:
Vaccine
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
Administration Route(s): [4]
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Labeler Name: [5]
    Sanofi Pasteur Inc.
    Labeler Code:
    49281
    Product Label ID:
    613aaac9-ec18-4b22-addb-599e1193e6f5
    FDA Application Number: [6]
    BLA103915
    Marketing Category: [8]
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date: [9]
    05-22-1953
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 49281-915?

    The NDC code 49281-915 is assigned by the FDA to the product Yf-vax which is a vaccine label product labeled by Sanofi Pasteur Inc.. The generic name of Yf-vax is yellow fever virus strain 17d-204 live antigen. The product's dosage form is injection, powder, lyophilized, for suspension and is administered via subcutaneous form. The product is distributed in 2 packages with assigned NDC codes 49281-915-01 5 vial, single-dose in 1 package / .5 ml in 1 vial, single-dose (49281-915-58), 49281-915-05 1 vial, multi-dose in 1 package / 2.5 ml in 1 vial, multi-dose (49281-915-68). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Yf-vax?

    YF-VAX is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories:

    What are Yf-vax Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Yf-vax UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN (UNII: PY4EET359T)
    • YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN (UNII: PY4EET359T) (Active Moiety)

    Which are Yf-vax Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Yf-vax?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 1292826 - yellow fever vaccine (generic for YF-Vax) Injectable Suspension
    • RxCUI: 1292826 - yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injectable Suspension
    • RxCUI: 1292828 - YF-VAX Injectable Suspension
    • RxCUI: 1292828 - yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injectable Suspension [YF-Vax]
    • RxCUI: 1292828 - YF-Vax 4000 UNT/ML Injectable Suspension

    Which are the Pharmacologic Classes for Yf-vax?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Patient Education

    Yellow Fever Vaccine


    What is yellow fever? Yellow fever is a serious disease caused by the yellow fever virus. It is found in certain parts of Africa and South America. Yellow fever is spread through the bite of an infected mosquito. It cannot be spread person to person by direct contact. People with yellow fever disease usually have to be hospitalized. Yellow fever can cause: fever and flu-like symptoms jaundice (yellow skin or eyes) bleeding from multiple body sites liver, kidney, respiratory and other organ failure death (20 to 50% of serious cases) Yellow fever vaccine is a live, weakened virus. It is given as a single shot. For people who remain at risk, a booster dose is recommended every 10 years. Yellow fever vaccine may be given at the same time as most other vaccines.
    [Learn More]


    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".